These medicines work by harnessing gut-brain hormonal pathways to reduce appetite and change food intake behaviour, a far more targeted approach than telling patients only to eat less and move more
Medicare just moved in the opposite direction on the most-discussed drug class in the world
Back to Journals International Journal of General Medicine Volume 18 Exploring the Mechanisms of Gastroesophageal Reflux Disease Based on the Brain-Gut Axis Theory Authors Du S , Zhang L , Chen Y, Zhang Q, Chen B, Chen S Received 5 August 2025 Accepted for publication 25 October 2025 Published 8 November 2025 Volume 2025:18 Pages 68336845 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Xudong Zhu Siqi Du, 1, * Lili Zhang, 1, * Yun Chen, 2 Qingyu Zhang, 3 Biwei Chen, 1 Shaozong Chen 4, 5 1 Shandong University of Traditional Chinese Medicine, Jinan, Shandong, Peoples Republic of China
How GLP-1 Medications Support Weight Loss Mechanism of Action of GLP-1 Medications GLP-1 medications mimic the action of the GLP-1 hormone, which is naturally produced in the intestines in response to food intake
Aashish et al., Efficacy and safety of fixed dose combination of Sitagliptin, metformin, and pioglitazone in type 2 Diabetes (IMPACT study): a randomized controlled trial, Clin
When dizziness comes with those features, it moves from a tolerable side effect to a potential emergency that needs urgent evaluation
